Anesth Pain Med.  2022 Apr;17(2):206-212. 10.17085/apm.21080.

Cause of postoperative mortality in patients with end-stage renal disease

• Song S
• Cho C
• Park SY
• Cho HB
• Yoo JH
• Kim MG
• Chung JW
• Kim SH

• KMID: 2531697
• DOI: http://doi.org/10.17085/apm.21080

Abstract

Background
The number of patients with end-stage renal disease (ESRD) who are dependent on hemodialysis is increasing rapidly. As a result, more patients with ESRD need surgery. These patients have a significantly higher risk of postoperative death than those with normal kidney function. Therefore, this study analyzed the causes of postoperative mortality in ESRD patients undergoing surgery under general anesthesia and the risk factors for postoperative mortality. Methods: This retrospective analysis examined the mortality of ESRD patients, 20 to 80 years old, undergoing surgery under general anesthesia. We excluded patients who underwent cardiac, cancer, or emergency surgery or organ transplantation from the analysis. The primary outcome was the cause of postoperative 30-day mortality in ESRD patients. We also assessed the mortality rate and risk factors. Results: There were 2,459 eligible ESRD patients. When patients underwent multiple surgeries during the study period, only the last surgery was considered. In total, 167 patients died during the study period, including 65 within 30 days postoperatively. The cause of death was sepsis in 22 cases (33.8%) and a major cardiac event in 16 (24.6%). Atrial fibrillation, current angina, previous myocardial infarction, asthma, lower hemoglobin and albumin levels, and a larger intraoperative colloid volume were likely to increase mortality. Conclusions: Our study suggests that immunological issues have a significant role in the death of ESRD patients after general anesthesia.

Keyword

Cause of death; End-stage renal disease; General anesthesia; Infection

Reference

1. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012; 120:c179–84.

2. Kanda H, Hirasaki Y, Iida T, Kanao-Kanda M, Toyama Y, Chiba T, et al. Perioperative management of patients with end-stage renal disease. J Cardiothorac Vasc Anesth. 2017; 31:2251–67.

3. Hall JE, Mouton AJ, da Silva AA, Omoto ACM, Wang Z, Li X, et al. Obesity, kidney dysfunction, and inflammation: interactions in hypertension. Cardiovasc Res. 2021; 117:1859–76.

4. Hamrahian SM, Falkner B. Hypertension in chronic kidney disease. Adv Exp Med Biol. 2017; 956:307–25.

5. Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016; 12:73–81.

6. Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, et al. US renal data system 2019 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2020; 75(1 Suppl 1):A6–7.

7. Korean Society of Nephrology. 2019 Korean ESRD registry. Seoul: Korean Society of Nephrology;2019.

8. Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017; 389:1238–52.

9. Palamuthusingam D, Johnson DW, Hawley CM, Pascoe E, Sivalingam P, Fahim M. Perioperative outcomes and risk assessment in dialysis patients: current knowledge and future directions. Intern Med J. 2019; 49:702–10.

10. Mathew A, Devereaux PJ, O'Hare A, Tonelli M, Thiessen-Philbrook H, Nevis IF, et al. Chronic kidney disease and postoperative mortality: a systematic review and meta-analysis. Kidney Int. 2008; 73:1069–81.

11. Chikuda H, Yasunaga H, Horiguchi H, Takeshita K, Kawaguchi H, Matsuda S, et al. Mortality and morbidity in dialysis-dependent patients undergoing spinal surgery: analysis of a national administrative database in Japan. J Bone Joint Surg Am. 2012; 94:433–8.

12. Brakoniecki K, Tam S, Chung P, Smith M, Alfonso A, Sugiyama G. Mortality in patients with end-stage renal disease and the risk of returning to the operating room after common general surgery procedures. Am J Surg. 2017; 213:395–8.

13. Currie A, Malietzis G, Askari A, Nachiappan S, Swift P, Jenkins JT, et al. Impact of chronic kidney disease on postoperative outcome following colorectal cancer surgery. Colorectal Dis. 2014; 16:879–85.

14. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016; 315:801–10.

15. Nagayoshi Y, Kawano H, Kojima S, Soejima H, Kaikita K, Nakayama M, et al. Significance of coronary vasospasm in the perioperative management of non-cardiac surgery. Circ J. 2012; 76:1965–71.

16. Briasoulis A, Bakris GL. Chronic kidney disease as a coronary artery disease risk equivalent. Curr Cardiol Rep. 2013; 15:340.

17. Lieberman JR, Fuchs MD, Haas SB, Garvin KL, Goldstock L, Gupta R, et al. Hip arthroplasty in patients with chronic renal failure. J Arthroplasty. 1995; 10:191–5.

18. Sakalkale DP, Hozack WJ, Rothman RH. Total hip arthroplasty in patients on long-term renal dialysis. J Arthroplasty. 1999; 14:571–5.

19. De la Garza Ramos R, Jain A, Nakhla J, Nasser R, Puvanesarajah V, Hassanzadeh H, et al. Postoperative morbidity and mortality after elective anterior cervical fusion in patients with chronic and end-stage renal disease. World Neurosurg. 2016; 95:480–5.

20. Erkocak OF, Yoo JY, Restrepo C, Maltenfort MG, Parvizi J. Incidence of infection and inhospital mortality in patients with chronic renal failure after total joint arthroplasty. J Arthroplasty. 2016; 31:2437–441.

21. Rosenfeldt F, Wilson M, Lee G, Kure C, Ou R, Braun L, et al. Oxidative stress in surgery in an ageing population: pathophysiology and therapy. Exp Gerontol. 2013; 48:45–54.

22. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008; 3:1526–33.

23. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-8. Erratum in: Kidney Int. 2008; 74:393.

24. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer. 1999; 80:880–8.

25. Cendoroglo M, Jaber BL, Balakrishnan VS, Perianayagam M, King AJ, Pereira BJ. Neutrophil apoptosis and dysfunction in uremia. J Am Soc Nephrol. 1999; 10:93–100.

26. Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G, et al. Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol 2005; 16: 2431-8. Erratum in: J Am Soc Nephrol. 2005; 16:2814.

27. Memoli B, Postiglione L, Cianciaruso B, Bisesti V, Cimmaruta C, Marzano L, et al. Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients. Kidney Int. 2000; 58:417–24.

28. Pecoits-Filho R, Gonçalves S, Barberato SH, Bignelli A, Lindholm B, Riella MC, et al. Impact of residual renal function on volume status in chronic renal failure. Blood Purif. 2004; 22:285–92.

29. Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, et al. CRIC Study Investigators. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol. 2012; 7:1938–46.

30. Yao Q, Axelsson J, Stenvinkel P, Lindholm B. Chronic systemic inflammation in dialysis patients: an update on causes and consequences. ASAIO J. 2004; 50:lii–lvii.